Lenvima plus Keytruda with TACE significantly improved progression-free survival in unresectable, non-metastatic hepatocellular carcinoma compared to TACE with placebo. The study reported a median ...

The addition of PD-1 inhibitors to first-line treatment with transarterial chemoembolization (TACE) plus lenvatinib for hepatocellular carcinoma (HCC). “PD-1 inhibitors have been recognized as an ...

Adding Imfinzi and Avastin to transarterial chemoembolization led to a 23% reduction in the risk of progression or death in patients with liver cancer. Patients with unresectable hepatocellular ...

Prayagraj: Kamala Nehru Memorial Hospital (KNMH) successfully performed its first-ever Trans-Arterial Chemoembolization (TACE) procedure on a two-year.

Researchers sought to determine an effective approach to predict postembolization fever in patients undergoing TACE.

Introduction Transarterial chemoembolization (TACE) combined with radioactive seed implantation has emerged as an effective locoregional strategy for treating hepatocellular carcinoma (HCC).

Tick marks indicate censoring of data. No participants had an albumin-bilirubin grade of 3, so this group has not been included in subgroup definitions here. BCLC=Barcelona Clinic Liver Cancer.

SAN FRANCISCO — Adding transarterial chemoembolization (TACE) to treatment with lenvatinib (Lenvima) significantly improved survival compared to levantinib alone in patients with advanced ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter arterial chemoembolization alone and with microwave ablation yielded comparable overall survival ...